Full programme

Session D.02: Treatment and Prevention
Thursday 4 May 2017 10:55 - 12:20

Chairs: Debbie van Baarle & Mark Schleiss

10:55 - 11:10
CMV-specific CD4+ T cells in CMV-IgG-seronegative individuals protect from CMV viremia following transplantation with a CMV-seropositive donor kidney Nicolle Litjens, Senior Scientist Erasmus Medical Center, Rotterdam, Netherlands
11:10 - 11:25
KLRG1+ CD8 T cells induced by cytomegalovirus vector expressing NKG2D ligand RAE-1γ provide robust protection against tumor challenge Tihana Trsan Faculty of Medicine, University of Rijeka, Rijeka, Croatia
11:25 - 11:40
Disabled Infectious Single Cycle (DISC) Cytomegalovirus Vaccine Encoding Pentameric Complex is Completely Protective Against Congenital Guinea Pig CMV Alistair McGregor Texas A&M University Health Science Center, College Station, United States of America
11:40 - 12:20
Keynote Lecture: A CMV Vaccine Can Be Made Now Stanley Plotkin, Emeritus Professor University of Pennsylvania, Doylestown, United States of America
CMV 2017: the 6th International congenital CMV conference/16th International CMV/betaherpesvirus workshop in 2017<